Skip to main content
Log in

Immuncheckpointinhibitoren

Neoadjuvante Immuntherapie beim Kolonfrühkarzinom

  • Journal club
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

1

Literatur

  1. Chalabi M et al. Nat Med. 2020;26(4):566-76

  2. Le DT et al. N Engl J Med. 2015;372(26):2509-20

  3. Deng Z et al. Clin Genet. 2020;97(1):25-38

  4. Guastadisegni C et al. Eur J Cancer. 2010;46(15):2788-98

  5. Gkekas I et al. Anticancer Res. 2017;37(12):6563-74

  6. Xu C et al. BMJ. 2018;363:k4226

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Alissa Jell, Dirk Wilhelm or Helmut Friess.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jell, A., Wilhelm, D. & Friess, H. Neoadjuvante Immuntherapie beim Kolonfrühkarzinom. InFo Hämatol Onkol 24, 28–29 (2021). https://doi.org/10.1007/s15004-021-8613-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-021-8613-y

Navigation